Clinical Trial Update: Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART) [NA]

View source ↗

Summary

This clinical trial update describes the PART study, which aims to prevent allosensitization in patients who have failed a first renal transplant; the trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplant Failure

Snippet

Sponsor: University of British Columbia | Conditions: Kidney Transplant, Kidney Transplant Failure | NA | Status: NOT_YET_RECRUITING